Display Settings:

Format

Send to:

Choose Destination

Screening for colorectal cancer : an updated systematic review

Author(s):
Whitlock, Evelyn P, author
Pignone, Michael. Screening for colorectal cancer in adults
United States Agency for Healthcare Research and Quality, issuing body
Oregon Health & Science University Evidence-based Practice Center, author
Title(s):
Screening for colorectal cancer : an updated systematic review / investigators, Evelyn P Whitlock, Jennifer Lin, Elizabeth Liles, Tracy Beil, Rongwei Fu, Elizabeth O'Connor, Rebecca Newton Thompson, and Taryn Cardenas ; Oregon Evidence-based Practice Center.
Series:
Evidence syntheses ; no. 65.1
[AHRQ publication] ; report no.: 08-05-05124-EF-1
Country of Publication:
United States
Publisher:
Rockville (MD) : Agency for Healthcare Research and Quality (US), October 2008.
Description:
1 online resource
Language:
English
Electronic Links:
http://www.ncbi.nlm.nih.gov/books/NBK35179/
Summary:
PURPOSE: We conducted a systematic review of five key questions to assist the U.S. Preventive Services Task Force (USPSTF) in updating its 2002 recommendation for colorectal cancer (CRC) screening in average-risk adults aged 50 years or older using home fecal occult blood testing (FOBT), flexible sigmoidoscopy (FS), FS and FOBT, colonoscopy, or double-contrast barium enema (DCBE). Key questions for this updated review primarily focused on evidence gaps from the previous review: 1) the accuracy (one-time test performance characteristics) and potential harms of newer CRC screening tests--fecal immunochemical tests (FIT), high-sensitivity FOBT, fecal DNA testing, and CT colonography (CTC)--as possible substitutes for currently recommended CRC screening modalities; 2) updating of evidence on the impact of CRC screening on mortality and to estimate the accuracy and harms of colonoscopy and FS in the community setting. A concurrent decision analysis done by others addressed screening program performance, and compared the life-years gained using different CRC screening tests, test intervals, and stopping ages. CONCLUSIONS: Based on currently available evidence, refinements in current CRC screening recommendations to add some fecal tests appear warranted. Given potential harms and variation in test accuracy, emphasis on quality standards for implementation of recommended operator-dependent CRC screening tests also appears prudent. Re-evaluation may be appropriate once ongoing RCTs, particularly evaluating CTC, but also evaluating FS and fecal DNA, report their results. Screening for CRC has a rapidly evolving science base, such that guidance may be expected to change as additional research becomes available.
MeSH:
Colorectal Neoplasms/diagnosis*
Colorectal Neoplasms/mortality
Cost-Benefit Analysis
Outcome and Process Assessment (Health Care)
Publication Type(s):
Review
Notes:
Title from HTML header.
Updates Screening for colorectal cancer in adults / Michael P. Pignone, Melissa Rich, Steven Teutsch, Alfred Berg, and Kathleen Lohr. 2002.
Includes bibliographical references.
Includes bibliographical references.
Issued also in print.
This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) Center for Health Research, Kaiser Permanente, 3800 North Interstate Avenue, Portland, OR 97227. under contract to the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services, 540 Gaither Road, Rockville, MD 20850. www.ahrq.gov Rockville, MD (Contract No. 290-2007-10057-I).
Description based on version viewed November 13, 2013.
NLM ID:
101618132 [Book]

Supplemental Content

Loading ...
Write to the Help Desk